<?xml version="1.0" encoding="UTF-8"?>
<p>There were 9.3, 3.5, and 18.2 times increases in MMP-2 and MMP-9 levels in PM
 <sub>10</sub>-exposed cells. The treatment of 10
 <sup>−5</sup>, 10
 <sup>−4</sup>, and 10
 <sup>−3</sup> /mL (
 <italic>v</italic>/
 <italic>v</italic> %) of MEO significantly decreased the MMP-2 mRNA expressions in PM
 <sub>10</sub>-treated cells by 26.0%, 68.5%, and 86.6%. Also, the production of MMP-9 in MEO-treated cells at the concentrations of 10
 <sup>−4</sup> and 10
 <sup>−3</sup> /mL (
 <italic>v</italic>/
 <italic>v</italic> %) was lower than in the PM
 <sub>10</sub>-treated cells (
 <xref ref-type="fig" rid="pharmaceuticals-14-00002-f004">Figure 4</xref>D).
</p>
